USMJ and PURA Schedule Joint Online Presentation to Review $2 Million and $5 Million Forecast Progress and Next Dividends
March 09 2017 - 8:38AM
InvestorsHub NewsWire
Dallas, TX – March 9,
2017 -- InvestorsHub NewsWire -- North American Cannabis
Holdings, Inc. (USOTC:
USMJ) and Puration, Inc. (USOTC:
PURA) today announced a joint on demand, online
presentation scheduled to be published on both Companies websites
tomorrow, March 10, 2017. PURA’s operation is a spinoff from
USMJ and the two companies work closely together with PURA
producing EVERx CBD Infused Water
under a license from USMJ. The presentation will include a
updates on progress to date toward the USMJ $2 million revenue
forecast and the PURA $3 million revenue forecast. The
presentation will also include updates on USMJ’s ongoing progress
to launch a retail cannabis payment system with Alternet Systems,
Inc. (USOTC:
ALYI) in a transaction to include a dividend of ALYI
stock to USMJ shareholders. Likewise, the presentation will
include an update on PURA’s transaction with Spanish Peaks
ScrumpDelicacies and ML Capital Group (USOTC:
MLCG) and the planned issue ScrumpDelicacies stock in
dividend distributions to PURA and MLCG shareholders.
To learn more about North American Cannabis
Holdings: growusmj.com.
To learn more about
Puration:
purationinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies’ contracts, the companies’ liquidity position, the
companies’ ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
North American Cannabis Holdings Contact:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com
ML Capital (CE) (USOTC:MLCG)
Historical Stock Chart
From Jan 2025 to Feb 2025
ML Capital (CE) (USOTC:MLCG)
Historical Stock Chart
From Feb 2024 to Feb 2025